Top Industry Analysts Rank Veeva Systems Among Largest, Most Strategic Software Vendors in Life Sciences
August 18 2016 - 7:03AM
Business Wire
Veeva’s industry cloud solutions gain momentum
as companies unify business processes for faster time to market and
greater compliance
As life sciences companies continue their transition from legacy
on-premises and horizontal cloud software to industry-specific
cloud applications, Veeva Systems (NYSE:VEEV) is strengthening its
position as a fast-growing, strategic vendor in the industry across
its most critical functions. According to Gartner, Veeva’s
extensive cloud-based multitenant software solution set across
research and development (R&D) and commercial is building the
company into a strategic-level vendor for global pharma and biotech
clients.1
Increased complexity in life sciences – from global stakeholder
ecosystems to regulatory requirements – is driving organizations to
streamline operations to be more efficient and agile. This is in an
effort to accelerate innovation and get products to market faster
and more effectively on a global scale. Organizations are
implementing new cloud approaches to improve collaboration and
provide smarter ways of working.
As a result, the industry is increasingly relying on Veeva’s
applications to streamline their global business operations, with
35 of the top 50 pharmaceutical companies using Veeva Vault to
unify their processes and content on a single platform in the areas
of commercial, clinical, regulatory, quality and medical.2
Customers are turning to Veeva to help them improve overall
business agility, compliance, and risk mitigation.
Over the next five years, Gartner expects migration to
multichannel marketing to strengthen and grow within pharma and
recognized Veeva as one of only two vendors to offer complete CRM
products, support, and services across most of the globe.3 Veeva is
in the market share leadership position of the pharma CRM vendor
landscape.4
According to IDC Health Insights, Veeva’s continued momentum in
the sales and marketing space has strengthened its leadership in
the industry.5 “Veeva has leveraged its strong position in the life
science CRM space to provide an optimized omni-channel solution for
its customers, with access to its cloud-based content management,
master data management, and system-wide customer data,” according
to the report.
In R&D, Vault Clinical, Vault RIM, and Vault Quality are
helping companies streamline their end-to-end clinical trial
processes, respond faster to business changes and health authority
requests, and integrate their quality processes and content. Within
commercial operations, Veeva Commercial Cloud is improving how life
sciences companies bring together customer data, compliant content,
and multichannel engagement to market and sell more effectively.
While Veeva Medical Solutions help organizations discover, target,
and engage the right opinion leaders.
“There is a significant shift occurring in the industry to cloud
applications that streamline and unify business processes,” said
Paul Shawah, vice president of product marketing at Veeva. “Our
focus on industry-specific applications is helping our customers
transform their R&D, commercial, and medical operations to
support faster product launches and quickly adopt new business
models. Industry analysts validate that we are gaining momentum as
a strategic partner to the industry.”
Additional Information
Stay updated on the latest Veeva news on LinkedIn:
linkedin.com/company/veeva-systemsFollow @veevasystems on Twitter:
twitter.com/veevasystemsLike Veeva on Facebook:
facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the
global life sciences industry. Committed to innovation, product
excellence, and customer success, Veeva has more than 400
customers, ranging from the world's largest pharmaceutical
companies to emerging biotechs. Veeva is headquartered in the San
Francisco Bay Area, with offices in Europe, Asia, and Latin
America. For more information, visit www.veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the
market demand for and acceptance of Veeva’s products and services,
the results from use of Veeva’s products and services, and general
business conditions, particularly in the life sciences industry.
Any forward-looking statements contained in this press release are
based upon Veeva’s historical performance and its current plans,
estimates, and expectations, and are not a representation that such
plans, estimates, or expectations will be achieved. These
forward-looking statements represent Veeva’s expectations as of the
date of this press announcement. Subsequent events may cause these
expectations to change, and Veeva disclaims any obligation to
update the forward-looking statements in the future. These
forward-looking statements are subject to known and unknown risks
and uncertainties that may cause actual results to differ
materially. Additional risks and uncertainties that could affect
Veeva’s financial results are included under the captions, “Risk
Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on
Form 10-Q for the period ended April 30, 2016. This is
available on the company’s website at veeva.com under the Investors
section and on the SEC’s website at sec.gov. Further information on
potential risks that could affect actual results will be included
in other filings Veeva makes with the SEC from time to time.
1 Stephen Davies (Gartner: March 18, 2016), Market Guide for CRM
in Pharma and Biotech2 As of April 30, 2016.3 Stephen Davies
(Gartner: March 18, 2016), Market Guide for CRM in Pharma and
Biotech4 Stephen Davies (Gartner: March 18, 2016), Market Guide for
CRM in Pharma and Biotech5 Alan S. Louie, Ph.D., Michael Townsend,
Eric Newmark (IDC Health Insights: June 2016), Business Strategy:
Top Software Vendors in the Life Science Industry, 2015
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160818005320/en/
Veeva SystemsRoger Villareal,
925-264-8885roger.villareal@veeva.comorLisa Barbadora,
610-420-3413pr@veeva.com
Veeva Systems (NYSE:VEEV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Veeva Systems (NYSE:VEEV)
Historical Stock Chart
From Apr 2023 to Apr 2024